Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/21480951

Download in:

View as

General Info

PMID
21480951